{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:11:53Z","timestamp":1794251513505,"version":"4.9.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008590","name":"Dr. Ralph and Marian Falk Medical Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG065240"],"award-info":[{"award-number":["R01AG065240"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS115903"],"award-info":[{"award-number":["R01NS115903"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R21NS107897"],"award-info":[{"award-number":["R21NS107897"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"a Harrington Discovery Institute Rare Disease Scholar Award"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mitochondrial dysfunction is a common hallmark of neurological disorders, and reducing mitochondrial damage is considered a promising neuroprotective therapeutic strategy. Here, we used high-throughput small molecule screening to identify CHIR99021 as a potent enhancer of mitochondrial function. CHIR99021 improved mitochondrial phenotypes and enhanced cell viability in several models of Huntington\u2019s disease (HD), a fatal inherited neurodegenerative disorder. Notably, CHIR99201 treatment reduced HD-associated neuropathology and behavioral defects in HD mice and improved mitochondrial function and cell survival in HD patient-derived neurons. Independent of its known inhibitory activity against glycogen synthase kinase 3 (GSK3), CHIR99021 treatment in HD models suppressed the proteasomal degradation of calpastatin (CAST), and subsequently inhibited calpain activation, a well-established effector of neural death, and Drp1, a driver of mitochondrial fragmentation. Our results established CAST-Drp1 as a druggable signaling axis in HD pathogenesis and highlighted CHIR99021 as a mitochondrial function enhancer and a potential lead for developing HD therapies.<\/jats:p>","DOI":"10.1038\/s41467-021-25651-y","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T06:04:08Z","timestamp":1630908248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Small-molecule suppression of calpastatin degradation reduces neuropathology in models of Huntington\u2019s disease"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4047-7340","authenticated-orcid":false,"given":"Di","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anniefer","family":"Magpusao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriy","family":"Fedorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benlian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9578-3890","authenticated-orcid":false,"given":"Xin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,6]]},"reference":[{"key":"25651_CR1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.neuron.2017.09.055","volume":"96","author":"T Misgeld","year":"2017","unstructured":"Misgeld, T. & Schwarz, T. L. Mitostasis in neurons: maintaining mitochondria in an extended cellular architecture. Neuron 96, 651\u2013666 (2017).","journal-title":"Neuron"},{"key":"25651_CR2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin, M. T. & Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787\u2013795 (2006).","journal-title":"Nature"},{"key":"25651_CR3","doi-asserted-by":"crossref","unstructured":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell 72, 971\u2013983 (1993).","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"25651_CR4","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.3155875","volume":"227","author":"GA Graveland","year":"1985","unstructured":"Graveland, G. A., Williams, R. S. & DiFiglia, M. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease. Science 227, 770\u2013773 (1985).","journal-title":"Science"},{"key":"25651_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan, P. & Tabrizi, S. J. Huntington\u2019s disease: a clinical review. Eur. J. Neurol. 25, 24\u201334 (2018).","journal-title":"Eur. J. Neurol."},{"key":"25651_CR6","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1038\/emboj.2012.65","volume":"31","author":"V Costa","year":"2012","unstructured":"Costa, V. & Scorrano, L. Shaping the role of mitochondria in the pathogenesis of Huntington\u2019s disease. EMBO J. 31, 1853\u20131864 (2012).","journal-title":"EMBO J."},{"key":"25651_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1172\/JCI45691","volume":"121","author":"F Mochel","year":"2011","unstructured":"Mochel, F. & Haller, R. G. Energy deficit in Huntington disease: why it matters. J. Clin. Investig. 121, 493\u2013499 (2011).","journal-title":"J. Clin. Investig."},{"key":"25651_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui, L. et al. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127, 59\u201369 (2006).","journal-title":"Cell"},{"key":"25651_CR9","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","volume":"13","author":"YS Choo","year":"2004","unstructured":"Choo, Y. S., Johnson, G. V., MacDonald, M., Detloff, P. J. & Lesort, M. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum. Mol. Genet. 13, 1407\u20131420 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"25651_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nm.2313","volume":"17","author":"W Song","year":"2011","unstructured":"Song, W. et al. Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat. Med. 17, 377\u2013382 (2011).","journal-title":"Nat. Med."},{"key":"25651_CR11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/hmg\/ddr475","volume":"21","author":"UP Shirendeb","year":"2012","unstructured":"Shirendeb, U. P. et al. Mutant huntingtin\u2019s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington\u2019s disease. Hum. Mol. Genet. 21, 406\u2013420 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"25651_CR12","first-page":"789","volume":"126","author":"X Qi","year":"2013","unstructured":"Qi, X., Qvit, N., Su, Y. C. & Mochly-Rosen, D. A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J. Cell Sci. 126, 789\u2013802 (2013).","journal-title":"J. Cell Sci."},{"key":"25651_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12646","volume":"7","author":"X Guo","year":"2016","unstructured":"Guo, X. et al. VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington\u2019s disease. Nat. Commun. 7, 12646 (2016).","journal-title":"Nat. Commun."},{"key":"25651_CR14","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1172\/JCI70911","volume":"123","author":"X Guo","year":"2013","unstructured":"Guo, X. et al. Inhibition of mitochondrial fragmentation diminishes Huntington\u2019s disease-associated neurodegeneration. J. Clin. Investig. 123, 5371\u20135388 (2013).","journal-title":"J. Clin. Investig."},{"key":"25651_CR15","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.nbd.2011.08.016","volume":"45","author":"MC Chiang","year":"2012","unstructured":"Chiang, M. C., Chern, Y. & Huang, R. N. PPARgamma rescue of the mitochondrial dysfunction in Huntington\u2019s disease. Neurobiol. Dis. 45, 322\u2013328 (2012).","journal-title":"Neurobiol. Dis."},{"key":"25651_CR16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/hmg\/ddh082","volume":"13","author":"Q Ruan","year":"2004","unstructured":"Ruan, Q., Lesort, M., MacDonald, M. E. & Johnson, G. V. Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway. Hum. Mol. Genet. 13, 669\u2013681 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"25651_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","volume":"552","author":"LD Zorova","year":"2018","unstructured":"Zorova, L. D. et al. Mitochondrial membrane potential. Anal. Biochem. 552, 50\u201359 (2018).","journal-title":"Anal. Biochem."},{"key":"25651_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09291-x","volume":"10","author":"Y Zhao","year":"2019","unstructured":"Zhao, Y. et al. ATAD3A oligomerization causes neurodegeneration by coupling mitochondrial fragmentation and bioenergetics defects. Nat. Commun. 10, 1371 (2019).","journal-title":"Nat. Commun."},{"key":"25651_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel, J. P. & DiFiglia, M. Huntington disease. J. Neuropathol. Exp. Neurol. 57, 369\u2013384 (1998).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"25651_CR20","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter, R. J. et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation. J. Neurosci. 19, 3248\u20133257 (1999).","journal-title":"J. Neurosci."},{"key":"25651_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","volume":"35","author":"L Menalled","year":"2009","unstructured":"Menalled, L. et al. Systematic behavioral evaluation of Huntington\u2019s disease transgenic and knock-in mouse models. Neurobiol. Dis. 35, 319\u2013336 (2009).","journal-title":"Neurobiol. Dis."},{"key":"25651_CR22","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/npp.2011.24","volume":"36","author":"JQ Pan","year":"2011","unstructured":"Pan, J. Q. et al. AKT kinase activity is required for lithium to modulate mood-related behaviors in mice. Neuropsychopharmacology 36, 1397\u20131411 (2011).","journal-title":"Neuropsychopharmacology"},{"key":"25651_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493\u2013506 (1996).","journal-title":"Cell"},{"key":"25651_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.tins.2010.08.002","volume":"33","author":"AJ Milnerwood","year":"2010","unstructured":"Milnerwood, A. J. & Raymond, L. A. Early synaptic pathophysiology in neurodegeneration: insights from Huntington\u2019s disease. Trends Neurosci. 33, 513\u2013523 (2010).","journal-title":"Trends Neurosci."},{"key":"25651_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier, L. R. et al. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118, 127\u2013138 (2004).","journal-title":"Cell"},{"key":"25651_CR26","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow, E. J. et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 12, 1555\u20131567 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"25651_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1326-5-18","volume":"5","author":"H Wang","year":"2010","unstructured":"Wang, H., Chen, X., Li, Y., Tang, T. S. & Bezprozvanny, I. Tetrabenazine is neuroprotective in Huntington\u2019s disease mice. Mol. Neurodegener. 5, 18 (2010).","journal-title":"Mol. Neurodegener."},{"key":"25651_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross, C. A. & Tabrizi, S. J. Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 10, 83\u201398 (2011).","journal-title":"Lancet Neurol."},{"key":"25651_CR29","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.2337\/diabetes.51.10.2903","volume":"51","author":"GW Cline","year":"2002","unstructured":"Cline, G. W. et al. Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa\/fa) rats. Diabetes 51, 2903\u20132910 (2002).","journal-title":"Diabetes"},{"key":"25651_CR30","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature06968","volume":"453","author":"QL Ying","year":"2008","unstructured":"Ying, Q. L. et al. The ground state of embryonic stem cell self-renewal. Nature 453, 519\u2013523 (2008).","journal-title":"Nature"},{"key":"25651_CR31","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1093\/hmg\/ddv224","volume":"24","author":"M Fernandez-Nogales","year":"2015","unstructured":"Fernandez-Nogales, M. et al. Decreased glycogen synthase kinase-3 levels and activity contribute to Huntington\u2019s disease. Hum. Mol. Genet. 24, 5040\u20135052 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"25651_CR32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0361-9230(03)00141-2","volume":"61","author":"NI Wood","year":"2003","unstructured":"Wood, N. I. & Morton, A. J. Chronic lithium chloride treatment has variable effects on motor behaviour and survival of mice transgenic for the Huntington\u2019s disease mutation. Brain Res. Bull. 61, 375\u2013383 (2003).","journal-title":"Brain Res. Bull."},{"key":"25651_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.yjmcc.2018.12.004","volume":"127","author":"AU Joshi","year":"2019","unstructured":"Joshi, A. U., Ebert, A. E., Haileselassie, B. & Mochly-Rosen, D. Drp1\/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington\u2019s disease. J. Mol. Cell. Cardiol. 127, 125\u2013133 (2019).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"25651_CR34","unstructured":"Wagner, F. F. et al. Exploiting an Asp-Glu \u201cswitch\u201d in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia. Sci. Transl. Med. 10, eaam8460 (2018)."},{"key":"25651_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nature07451","volume":"456","author":"RA Hanna","year":"2008","unstructured":"Hanna, R. A., Campbell, R. L. & Davies, P. L. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin. Nature 456, 409\u2013412 (2008).","journal-title":"Nature"},{"key":"25651_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.tins.2016.01.007","volume":"39","author":"M Baudry","year":"2016","unstructured":"Baudry, M. & Bi, X. Calpain-1 and Calpain-2: the yin and yang of synaptic plasticity and neurodegeneration. Trends Neurosci. 39, 235\u2013245 (2016).","journal-title":"Trends Neurosci."},{"key":"25651_CR37","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/cdd.2014.151","volume":"22","author":"FM Menzies","year":"2015","unstructured":"Menzies, F. M. et al. Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity. Cell Death Differ. 22, 433\u2013444 (2015).","journal-title":"Cell Death Differ."},{"key":"25651_CR38","doi-asserted-by":"publisher","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","volume":"92","author":"E Brouillet","year":"1995","unstructured":"Brouillet, E. et al. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. Natl Acad. Sci. USA 92, 7105\u20137109 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25651_CR39","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1042\/bj3190683","volume":"319","author":"R Nath","year":"1996","unstructured":"Nath, R. et al. Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem. J. 319, 683\u2013690 (1996).","journal-title":"Biochem. J."},{"key":"25651_CR40","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/35012636","volume":"405","author":"MS Lee","year":"2000","unstructured":"Lee, M. S. et al. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360\u2013364 (2000).","journal-title":"Nature"},{"key":"25651_CR41","doi-asserted-by":"publisher","first-page":"10090","DOI":"10.1523\/JNEUROSCI.3237-08.2008","volume":"28","author":"P Paoletti","year":"2008","unstructured":"Paoletti, P. et al. Dopaminergic and glutamatergic signaling crosstalk in Huntington\u2019s disease neurodegeneration: the role of p25\/cyclin-dependent kinase 5. J. Neurosci. 28, 10090\u201310101 (2008).","journal-title":"J. Neurosci."},{"key":"25651_CR42","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1021\/acschembio.6b00306","volume":"11","author":"FF Wagner","year":"2016","unstructured":"Wagner, F. F. et al. Inhibitors of glycogen synthase kinase 3 with exquisite kinome-wide selectivity and their functional effects. ACS Chem. Biol. 11, 1952\u20131963 (2016).","journal-title":"ACS Chem. Biol."},{"key":"25651_CR43","doi-asserted-by":"publisher","first-page":"18866","DOI":"10.1016\/S0021-9258(19)47235-9","volume":"264","author":"M Maki","year":"1989","unstructured":"Maki, M. et al. Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene. J. Biol. Chem. 264, 18866\u201318869 (1989).","journal-title":"J. Biol. Chem."},{"key":"25651_CR44","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bbadis.2016.11.026","volume":"1863","author":"X Guo","year":"2017","unstructured":"Guo, X. & Qi, X. VCP cooperates with UBXD1 to degrade mitochondrial outer membrane protein MCL1 in model of Huntington\u2019s disease. Biochim. Biophys. Acta Mol. Basis Dis. 1863, 552\u2013559 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"25651_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1749-6632.2010.05629.x","volume":"1201","author":"CR Chang","year":"2010","unstructured":"Chang, C. R. & Blackstone, C. Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Ann. NY Acad. Sci. 1201, 34\u201339 (2010).","journal-title":"Ann. NY Acad. Sci."},{"key":"25651_CR46","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.tips.2004.07.006","volume":"25","author":"L Meijer","year":"2004","unstructured":"Meijer, L., Flajolet, M. & Greengard, P. Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol. Sci. 25, 471\u2013480 (2004).","journal-title":"Trends Pharmacol. Sci."},{"key":"25651_CR47","unstructured":"An, W. F. et al. Discovery of Potent and Highly Selective Inhibitors of GSK3b. In: Probe Reports from the NIH Molecular Libraries Program (NCBI, 2012)."},{"key":"25651_CR48","doi-asserted-by":"publisher","first-page":"588","DOI":"10.2337\/diabetes.52.3.588","volume":"52","author":"DB Ring","year":"2003","unstructured":"Ring, D. B. et al. Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 52, 588\u2013595 (2003).","journal-title":"Diabetes"},{"key":"25651_CR49","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nbt.3247","volume":"33","author":"O Bar-Nur","year":"2015","unstructured":"Bar-Nur, O. et al. Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage. Nat. Biotechnol. 33, 761\u2013768 (2015).","journal-title":"Nat. Biotechnol."},{"key":"25651_CR50","doi-asserted-by":"crossref","unstructured":"Ma, Y. et al. CHIR-99021 regulates mitochondrial remodelling via beta-catenin signalling and miRNA expression during endodermal differentiation. J. Cell Sci. 132, jcs229948 (2019).","DOI":"10.1242\/jcs.229948"},{"key":"25651_CR51","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0092-8674(02)00659-1","volume":"108","author":"T Moldoveanu","year":"2002","unstructured":"Moldoveanu, T. et al. A Ca(2+) switch aligns the active site of calpain. Cell 108, 649\u2013660 (2002).","journal-title":"Cell"},{"key":"25651_CR52","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","volume":"22","author":"J Gafni","year":"2002","unstructured":"Gafni, J. & Ellerby, L. M. Calpain activation in Huntington\u2019s disease. J. Neurosci. 22, 4842\u20134849 (2002).","journal-title":"J. Neurosci."},{"key":"25651_CR53","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/acel.12374","volume":"14","author":"K Cho","year":"2015","unstructured":"Cho, K. et al. Calpain-mediated cleavage of DARPP-32 in Alzheimer\u2019s disease. Aging cell 14, 878\u2013886 (2015).","journal-title":"Aging cell"},{"key":"25651_CR54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/NDT.S78226","volume":"11","author":"A Yildiz-Unal","year":"2015","unstructured":"Yildiz-Unal, A., Korulu, S. & Karabay, A. Neuroprotective strategies against calpain-mediated neurodegeneration. Neuropsychiatr. Dis. Treat. 11, 297\u2013310 (2015).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"25651_CR55","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuropharm.2018.01.022","volume":"133","author":"JJ Weber","year":"2018","unstructured":"Weber, J. J. et al. Calpastatin ablation aggravates the molecular phenotype in cell and animal models of Huntington disease. Neuropharmacology 133, 94\u2013106 (2018).","journal-title":"Neuropharmacology"},{"key":"25651_CR56","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.2527\/1999.7761467x","volume":"77","author":"ME Doumit","year":"1999","unstructured":"Doumit, M. E. & Koohmaraie, M. Immunoblot analysis of calpastatin degradation: evidence for cleavage by calpain in postmortem muscle. J. Anim. Sci. 77, 1467\u20131473 (1999).","journal-title":"J. Anim. Sci."},{"key":"25651_CR57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neulet.2012.07.066","volume":"526","author":"W Suwanjang","year":"2012","unstructured":"Suwanjang, W., Phansuwan-Pujito, P., Govitrapong, P. & Chetsawang, B. Calpastatin reduces calpain and caspase activation in methamphetamine-induced toxicity in human neuroblastoma SH-SY5Y cultured cells. Neurosci. Lett. 526, 49\u201353 (2012).","journal-title":"Neurosci. Lett."},{"key":"25651_CR58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2337\/db15-0963","volume":"65","author":"R Ni","year":"2016","unstructured":"Ni, R. et al. Mitochondrial calpain-1 disrupts ATP synthase and induces superoxide generation in type 1 diabetic hearts: a novel mechanism contributing to diabetic cardiomyopathy. Diabetes 65, 255\u2013268 (2016).","journal-title":"Diabetes"},{"key":"25651_CR59","doi-asserted-by":"publisher","first-page":"9278","DOI":"10.1523\/JNEUROSCI.2826-07.2007","volume":"27","author":"G Cao","year":"2007","unstructured":"Cao, G. et al. Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury. J. Neurosci. 27, 9278\u20139293 (2007).","journal-title":"J. Neurosci."},{"key":"25651_CR60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/cvr\/cvs163","volume":"96","author":"MA Smith","year":"2012","unstructured":"Smith, M. A. & Schnellmann, R. G. Calpains, mitochondria, and apoptosis. Cardiovasc. Res. 96, 32\u201337 (2012).","journal-title":"Cardiovasc. Res."},{"key":"25651_CR61","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.mito.2016.07.009","volume":"30","author":"K Tangmansakulchai","year":"2016","unstructured":"Tangmansakulchai, K. et al. Calpastatin overexpression reduces oxidative stress-induced mitochondrial impairment and cell death in human neuroblastoma SH-SY5Y cells by decreasing calpain and calcineurin activation, induction of mitochondrial fission and destruction of mitochondrial fusion. Mitochondrion 30, 151\u2013161 (2016).","journal-title":"Mitochondrion"},{"key":"25651_CR62","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nrm2275","volume":"8","author":"SA Detmer","year":"2007","unstructured":"Detmer, S. A. & Chan, D. C. Functions and dysfunctions of mitochondrial dynamics. Nat. Rev. Mol. Cell Biol. 8, 870\u2013879 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"25651_CR63","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.cmet.2013.03.002","volume":"17","author":"M Liesa","year":"2013","unstructured":"Liesa, M. & Shirihai, O. S. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 17, 491\u2013506 (2013).","journal-title":"Cell Metab."},{"key":"25651_CR64","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/sj.cdd.4402087","volume":"14","author":"K Meuer","year":"2007","unstructured":"Meuer, K. et al. Cyclin-dependent kinase 5 is an upstream regulator of mitochondrial fission during neuronal apoptosis. Cell Death Differ. 14, 651\u2013661 (2007).","journal-title":"Cell Death Differ."},{"key":"25651_CR65","doi-asserted-by":"publisher","first-page":"e12912","DOI":"10.1111\/acel.12912","volume":"18","author":"S Jiang","year":"2019","unstructured":"Jiang, S., Shao, C., Tang, F., Wang, W. & Zhu, X. Dynamin-like protein 1 cleavage by calpain in Alzheimer\u2019s disease. Aging Cell 18, e12912 (2019).","journal-title":"Aging Cell"},{"key":"25651_CR66","doi-asserted-by":"publisher","first-page":"15803","DOI":"10.1073\/pnas.0808249105","volume":"105","author":"GM Cereghetti","year":"2008","unstructured":"Cereghetti, G. M. et al. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc. Natl Acad. Sci. USA 105, 15803\u201315808 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25651_CR67","first-page":"400.e8","volume":"28","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. Mitofusin 2 regulates axonal transport of calpastatin to prevent neuromuscular synaptic elimination in skeletal muscles. Cell Metab. 28, 400.e8\u2013414.e8 (2018).","journal-title":"Cell Metab."},{"key":"25651_CR68","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski, J. R., Zougman, A., Nagaraj, N. & Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359\u2013362 (2009).","journal-title":"Nat. Methods"},{"key":"25651_CR69","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1021\/ac025747h","volume":"74","author":"A Keller","year":"2002","unstructured":"Keller, A., Nesvizhskii, A. I., Kolker, E. & Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS\/MS and database search. Anal. Chem. 74, 5383\u20135392 (2002).","journal-title":"Anal. Chem."},{"key":"25651_CR70","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1021\/ac0341261","volume":"75","author":"AI Nesvizhskii","year":"2003","unstructured":"Nesvizhskii, A. I., Keller, A., Kolker, E. & Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646\u20134658 (2003).","journal-title":"Anal. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25651-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25651-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25651-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:19:02Z","timestamp":1669972742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25651-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,6]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["25651"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-25651-y","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740770557.793588518","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,6]]},"assertion":[{"value":"9 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5305"}}